Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia
about
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaImproving nucleoside analogs via lipid conjugation: Is fatter any better?Late-phase investigational approaches for the treatment of relapsed/refractory acute myeloid leukemia.Elacytarabine: lipid vector technology under investigation in acute myeloid leukemia.Novel therapeutics in acute myeloid leukemia.Clinical potential of elacytarabine in patients with acute myeloid leukemia.Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia.
P2860
Q34314177-1B3B1E7C-F76C-4FA9-8D90-55765E235A96Q36706248-6A40F7D1-47AD-437A-81BD-BD66735ADD60Q38042705-53D5FF93-A1A4-4C0F-BD6B-1038AFCF0AB8Q38078423-6BDF829E-7EC0-4DA3-AE5D-77998BD7185CQ38196346-A91F0677-AFB7-43AE-888F-3FE110F0DC37Q38282095-8AE88DB9-324F-4A3F-9DA9-97BEFF888877Q39374988-5FD10208-74DE-4792-88C4-E4EFF817AD02
P2860
Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@ast
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@en
type
label
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@ast
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@en
prefLabel
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@ast
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@en
P2093
P2860
P50
P1433
P1476
Elacytarabine, a novel 5'-elai ...... ractory acute myeloid leukemia
@en
P2093
David Rizzieri
Ronan Swords
Tove Flem Jacobsen
P2860
P356
10.1016/J.LEUKRES.2011.12.010
P577
2012-01-09T00:00:00Z